Underreporting of vertebral fractures on routine chest radiography.
暂无分享,去创建一个
B H Rowe | B. Rowe | S. Majumdar | I. Colman | S A Jackson | K. Siminoski | N Kim | G Raymond | H Jen | I Colman | K G Siminoski | A M Chahal | D Folk | S R Majumdar | H. Jen | A. M. Chahal | S. Jackson | G. Raymond | N. Kim | D. Folk | Brian H. Rowe | Ian Colman | Kerry Siminoski
[1] J. R. Landis,et al. The measurement of observer agreement for categorical data. , 1977, Biometrics.
[2] M. Hooper,et al. Randomized Trial of the Effects of Risedronate on Vertebral Fractures in Women with Established Postmenopausal Osteoporosis , 2000, Osteoporosis International.
[3] H. Genant,et al. Predicting vertebral fracture incidence from prevalent fractures and bone density among non-black, osteoporotic women , 1993, Osteoporosis International.
[4] R. Epstein,et al. Pre-existing fractures and bone mass predict vertebral fracture incidence in women. , 1991, Annals of internal medicine.
[5] P. Ross,et al. Clinical consequences of vertebral fractures. , 1997, The American journal of medicine.
[6] S. Majumdar,et al. Development and Initial Validation of a Risk Score for Predicting In‐Hospital and 1‐Year Mortality in Patients With Hip Fractures , 2004, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[7] Richard Platt,et al. Low frequency of treatment of osteoporosis among postmenopausal women following a fracture. , 2003, Archives of internal medicine.
[8] S. Gehlbach,et al. Recognition of Vertebral Fracture in a Clinical Setting , 2000, Osteoporosis International.
[9] Jacques P. Brown,et al. Determinants of health-related quality of life in women with vertebral fractures , 2005, Osteoporosis International.
[10] C. Roux,et al. Reporting of vertebral fractures on spine X-rays , 2005, Osteoporosis International.
[11] H K Genant,et al. Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: a randomized controlled trial. Vertebral Efficacy With Risedronate Therapy (VERT) Study Group. , 1999, JAMA.
[12] S. Cummings,et al. Fracture risk reduction with alendronate in women with osteoporosis: the Fracture Intervention Trial. FIT Research Group. , 2000, The Journal of clinical endocrinology and metabolism.
[13] T. Link,et al. Radiologic assessment of osteoporotic vertebral fractures: diagnostic and prognostic implications , 2005, European Radiology.
[14] C C Glüer,et al. Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomized clinical trial. Multiple Outcomes of Raloxifene Evaluation (MORE) Investigators. , 1999, JAMA.
[15] C. Cooper,et al. Incidence of clinically diagnosed vertebral fractures: A population‐based study in rochester, minnesota, 1985‐1989 , 1992, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[16] M. Dobritz,et al. Detection of osteoporotic vertebral fractures using multidetector CT , 2005, Osteoporosis International.
[17] S. A. Jackson,et al. Vertebral Fracture Definition from Population-Based Data: Preliminary Results from the Canadian Multicenter Osteoporosis Study (CaMos) , 2000, Osteoporosis International.
[18] M. Nevitt,et al. Vertebral fracture assessment using a semiquantitative technique , 1993, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.